Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News


Cognitive training, diet, exercise, and vascular management seen to improve cognition even in people with genetic predisposition for dementia (APOE e4)


How do genet­ics impact ear­ly inter­ven­tion for demen­tia? (Med­ical News Bul­letin):

Car­dio­vas­cu­lar and neu­ro­log­i­cal dis­eases, such as demen­tia, have been linked to dys­func­tion of a vari­a­tion of the apolipopro­tein E, or APOE, gene, called the APOE e4 allele…The Finnish Geri­atric Inter­ven­tion Study to Pre­vent Cog­ni­tive Impair­ment and Dis­abil­i­ty (FINGER) eval­u­at­ed whether the effec­tive­ness of lifestyle mod­i­fi­ca­tions for those at risk of Alzheimer’s dis­ease would be dif­fer­ent for those with or with­out the APOE e4 gene. This was a clin­i­cal tri­al includ­ing 60 to 77-year-old indi­vid­u­als from the gen­er­al pop­u­la­tion in Fin­land who were at-risk for car­dio­vas­cu­lar dis­eases and demen­tia…

The inter­ven­tion group was pro­vid­ed with spe­cial­ized cog­ni­tive train­ing, diet, exer­cise, and vas­cu­lar man­age­ment, where­as the con­trol group received reg­u­lar health advice only…The researchers per­formed genom­ic DNA tests from blood sam­ples to iden­ti­fy the pres­ence of APOE ?4 and neu­ropsy­cho­log­i­cal tests to deter­mine cog­ni­tion out­comes of all par­tic­i­pants over the course of 24 months.

The results showed that cog­ni­tion lev­els improved for those who par­tic­i­pat­ed in the inter­ven­tion groups. The lifestyle inter­ven­tions proved effec­tive for those with and with­out the APOE e4 gene. These results indi­cate that even those with a genet­ic pre­dis­po­si­tion for demen­tia can ben­e­fit from tar­get­ed lifestyle mod­i­fi­ca­tions. In fact, those who with the genet­ic sus­cep­ti­bil­i­ty may have received addi­tion­al ben­e­fits, how­ev­er, fur­ther research will be need­ed to con­firm these results. These find­ings empha­size the impor­tance of ear­ly active inter­ven­tions.”

The Study

Effect of the Apolipopro­tein E Geno­type on Cog­ni­tive Change Dur­ing a Mul­tido­main Lifestyle Inter­ven­tion: A Sub­group Analy­sis of a Ran­dom­ized Clin­i­cal Tri­al (JAMA Neu­rol­o­gy). From the abstract:

  • OBJECTIVE: To exam­ine whether the APOE e4 allele mod­i­fies the pre­vi­ous­ly report­ed sig­nif­i­cant cog­ni­tive ben­e­fits of a mul­tido­main lifestyle inter­ven­tion (pre­spec­i­fied sub­group analy­sis).
  • DESIGN, SETTING, AND PARTICIPANTS: The Finnish Geri­atric Inter­ven­tion Study to Pre­vent Cog­ni­tive Impair­ment and Dis­abil­i­ty (FINGER) was a ran­dom­ized clin­i­cal tri­al in 6 cen­ters across Fin­land (screen­ing and ran­dom­iza­tion per­formed from Sep­tem­ber 7, 2009, through Novem­ber 24, 2011; inter­ven­tion dura­tion, 2 years). Data analy­sis was per­formed from August 1, 2015, to March 31, 2016. The study pop­u­la­tion was at-risk old­er indi­vid­u­als from the gen­er­al pop­u­la­tion. Inclu­sion cri­te­ria were age of 60 to 77 years; Car­dio­vas­cu­lar Risk Fac­tors, Aging, and Demen­tia risk score of at least 6 points; and cog­ni­tion at a mean lev­el or slight­ly low­er than expect­ed for age. Indi­vid­u­als with demen­tia or sub­stan­tial cog­ni­tive impair­ment and con­di­tions that pre­vent­ed coop­er­a­tion or safe engage­ment in the inter­ven­tion were exclud­ed. APOE geno­type data were avail­able for 1175 of the 1260 par­tic­i­pants.
  • INTERVENTIONS: Par­tic­i­pants were ran­dom­ly assigned in a 1:1 ratio to a mul­tido­main inter­ven­tion group (diet, exer­cise, cog­ni­tive train­ing, and vas­cu­lar risk man­age­ment) or a con­trol group (gen­er­al health advice). Group allo­ca­tion was not active­ly dis­closed to par­tic­i­pants, and out­come asses­sors were masked to group allo­ca­tion.
  • MAIN OUTCOMES AND MEASURES: Pri­ma­ry out­come was change in cog­ni­tion mea­sured through a com­pre­hen­sive neu­ropsy­cho­log­i­cal test bat­tery. Analy­sis was based on mod­i­fied inten­tion to treat (par­tic­i­pants with at least 1 post base­line assess­ment).
  • RESULTS: A total of 1109 par­tic­i­pants were includ­ed in the analy­sis: 362 APOE e4 allele car­ri­ers (173 inter­ven­tion and 189 con­trol) and 747 non­car­ri­ers (380 inter­ven­tion and 367 con­trol). The APOE e4 car­ri­ers and non­car­ri­ers were not sig­nif­i­cant­ly dif­fer­ent at base­line (except for serum cho­les­terol level)…Intervention effect was not sig­nif­i­cant­ly dif­fer­ent between car­ri­ers and non­car­ri­ers.
  • CONCLUSIONS AND RELEVANCE: Healthy lifestyle changes may be ben­e­fi­cial for cog­ni­tion in old­er at-risk indi­vid­u­als even in the pres­ence of APOE-relat­ed genet­ic sus­cep­ti­bil­i­ty to demen­tia. Whether such ben­e­fits are more pro­nounced in APOE e4 car­ri­ers com­pared with non­car­ri­ers should be fur­ther inves­ti­gat­ed. The find­ings also empha­size the impor­tance of ear­ly pre­ven­tion strate­gies that tar­get mul­ti­ple mod­i­fi­able risk fac­tors simul­ta­ne­ous­ly.

News in Context:

Leave a Reply...

Loading Facebook Comments ...

Leave a Reply

Categories: Cognitive Neuroscience, Health & Wellness

Tags: , , , , , , , , , , , , , , ,

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters,  SharpBrains is an independent market research firm tracking how brain science can improve our health and our lives.

Search in our archives

Follow us and Engage via…

RSS Feed

Watch All Recordings Now (40+ Speakers, 12+ Hours)